Many retrospective studies underlined that an elevated SOCS3 expression significantly correlated with DFS and OS in patients with BC, colorectal cancer, gastric cancer, ovarian cancer, and prostatic cancer [52]. This evidence concerns the gene SOCS3 and ovarian carcinoma.